Researchers Have an Ethical Obligation to Disclose the Availability of Off-Label Marketed Drugs

American Journal of Bioethics 14 (4):52-52 (2014)
  Copy   BIBTEX

Abstract

No abstract

Categories

Keywords

Reprint years

DOI

10.1080/15265161.2014.889946

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,202

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

The Ethics of Disclosing to Research Subjects the Availability of Off-Label Marketed Drugs.Holly A. Taylor, Ellen Kuwana & Benjamin S. Wilfond - 2014 - American Journal of Bioethics 14 (4):51-51.
Do Researchers Have an Obligation to Actively Look for Genetic Incidental Findings?Catherine Gliwa & Benjamin E. Berkman - 2013 - American Journal of Bioethics 13 (2):32-42.
Speaking Off Label.Stephen R. Latham - 2010 - Hastings Center Report 40 (6):9-10.
Psychotropic drugs and paediatrics: a critical need for more clinical trials.Carl L. Tishler & Natalie S. Reiss - 2012 - Journal of Medical Ethics 38 (4):250-252.
Informed Consent and the Requirement to Ensure Understanding.Tom Walker - 2011 - Journal of Applied Philosophy 29 (1):50-62.
Five Un‐Easy Pieces of Pharmaceutical Policy Reform.Marc A. Rodwin - 2013 - Journal of Law, Medicine and Ethics 41 (3):581-589.
Ethical and social aspects on rare diseases.Dusanka Krajnovic - 2012 - Filozofija I Društvo 23 (4):32-48.
Off-Label Drug Use as a Consent and Health Regulation Issue in New Zealand.Rebecca Julia Cook - 2015 - Journal of Bioethical Inquiry 12 (2):251-258.
Off-label, off-limits? Parental awareness and attitudes towards off-label use in paediatrics.Claudia Wiesemann - 2009 - European Journal of Pediatrics 168:1473-1478.
When research seems like clinical care: a qualitative study of the communication of individual cancer genetic research results.Fiona A. Miller, Mita Giacomini, Catherine Ahern, Jason S. Robert & Sonya de Laat - 2008 - BMC Medical Ethics 9 (1):4.
Pharmacogenetics: Ethical issues and policy options.Allen E. Buchanan, Andrea Califano, Jeffrey Kahn, Elizabeth McPherson, John A. Robertson & Baruch A. Brody - 2002 - Kennedy Institute of Ethics Journal 12 (1):1-15.
Rooting Out Institutional Corruption to Manage Inappropriate Off‐Label Drug Use.Marc A. Rodwin - 2013 - Journal of Law, Medicine and Ethics 41 (3):654-664.

Analytics

Added to PP
2014-04-15

Downloads
11 (#1,070,627)

6 months
1 (#1,444,594)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references